← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Atgc, Inc.
Ypsilanti, MI
$4,801,284
Total funding
6
Grants
Funding over time
peak $1.4M · FY2017–23$2M$1.5M$1M$500K$0
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$4,801,284 · 6
By mechanism
R42$3,816,059 · 2
R41$985,225 · 4
Investigators at Atgc, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Novel methods to improve nuclease mediated homologous recombination$940,327
R42 · FY2023 · GM
Novel methods to improve nuclease mediated homologous recombination$854,843
R42 · FY2022 · GM
A nanoparticle delivery system for CRISPR/Cas9 based therapeutics$749,563
R42 · FY2018 · TR
A nanoparticle delivery system for CRISPR/Cas9 based therapeutics$732,982
R42 · FY2019 · TR
Novel methods to improve nuclease mediated homologous recombination, Administrative suppl$313,344
R42 · FY2022 · GM
Structure-based computational engineering of saCas9 PAM requirement$274,955
R41 · FY2023 · GM
Rapid egg bioreactor construction for Fabry disease therapeutics$259,520
R41 · FY2022 · GM
Ground state rabbit pluripotent stem cells$225,750
R41 · FY2017 · OD
A nanoparticle delivery system for CRISPR/Cas9 based therapeutics$225,000
R42 · FY2017 · TR
Novel methods to improve nuclease mediated homologous recombination$225,000
R41 · FY2017 · GM